Disc Medicine (IRON) Cash from Operations (2020 - 2026)
Disc Medicine's (IRON) quarterly Cash from Operations came in at 62236000.0 in Q1 2026, down 50.42% year-on-year from 125515535.97 in Q1 2025, and down 43.73% on a QoQ basis from 43300000.0 in Q4 2025.
Disc Medicine (IRON) Cash from Operations (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has 7 years of Cash from Operations data on file, last reported at 62236000.0 in Q1 2026.
- On a quarterly basis, Cash from Operations fell 50.42% year-over-year to 62236000.0 in Q1 2026; TTM through Mar 2026 was 201253000.0, a 97.88% decrease from a year earlier, with the FY2025 full-year figure at 180393000.0, down 92.06% from the prior year.
- Cash from Operations for Q1 2026 stood at 62236000.0, down from 43300000.0 in the prior quarter.
- Over the last five years, Cash from Operations for IRON reached as high as 7476000.0 in Q3 2023 and fell as low as 62236000.0 in Q1 2026.
- Historically, Cash from Operations has averaged 26604058.82 across 5 years, with a median of 17796000.0 in 2023.
- Across the five-year window, Cash from Operations surged 42.28% in 2022 and tumbled 211.3% in 2025, its largest moves.
- Year by year, Cash from Operations stood at 9665000.0 in 2022, then tumbled by 84.13% to 17796000.0 in 2023, then plunged by 54.94% to 27573000.0 in 2024, then slumped by 57.04% to 43300000.0 in 2025, then tumbled by 43.73% to 62236000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were 62236000.0 in Q1 2026, 43300000.0 in Q4 2025, and 47799000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Disc Medicine | 2.90 Bn | 2.90 Bn | - | -62.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -62.24 Mn |
| Mar 31, 2026 | -62.24 Mn |
| Dec 31, 2025 | -43.30 Mn |
| Dec 31, 2025 | -43.30 Mn |
| Sep 30, 2025 | -47.80 Mn |
| Sep 30, 2025 | -47.80 Mn |
| Jun 30, 2025 | -47.92 Mn |
| Jun 30, 2025 | -47.92 Mn |
| Mar 31, 2025 | -41.38 Mn |
| Mar 31, 2025 | -41.38 Mn |
| Dec 31, 2024 | -27.57 Mn |
| Dec 31, 2024 | -27.57 Mn |
| Sep 30, 2024 | -17.36 Mn |
| Sep 30, 2024 | -17.36 Mn |
| Jun 30, 2024 | -15.39 Mn |
| Jun 30, 2024 | -15.39 Mn |
| Mar 31, 2024 | -33.60 Mn |
| Mar 31, 2024 | -33.60 Mn |
| Dec 31, 2023 | -17.80 Mn |
| Dec 31, 2023 | -17.80 Mn |